Breaking News Instant updates and real-time market news.

WFC

Wells Fargo

$54.74

0.26 (0.48%)

, BYD

Boyd Gaming

$36.15

0.095 (0.26%)

04:55
05/16/18
05/16
04:55
05/16/18
04:55

Wells Fargo to hold a conference

9th Annual Gaming, Hospitality & Leisure Conference will be held in Las Vegas on May 15-16.

WFC

Wells Fargo

$54.74

0.26 (0.48%)

BYD

Boyd Gaming

$36.15

0.095 (0.26%)

SGMS

Scientific Games

$58.80

-0.5 (-0.84%)

RRR

Red Rock Resorts

$33.89

0.2 (0.59%)

MCRI

Monarch Casino

$43.89

0.47 (1.08%)

TSG

The Stars Group

$35.75

-0.75 (-2.05%)

TAST

Carrols Restaurant

$11.90

-0.05 (-0.42%)

EVRI

Everi Holdings

$7.48

0.03 (0.40%)

GDEN

Golden Entertainment

$29.76

0.92 (3.19%)

MGP

MGM Growth

$28.41

-0.26 (-0.91%)

PENN

Penn National

$33.98

0.23 (0.68%)

MGM

MGM Resorts

$31.73

-0.58 (-1.80%)

CZR

Caesars

$12.70

0.2 (1.60%)

ERI

Eldorado Resorts

$43.10

-0.1 (-0.23%)

  • 16

    May

  • 17

    May

  • 17

    May

  • 22

    May

  • 29

    May

  • 30

    May

  • 05

    Jun

  • 06

    Jun

WFC Wells Fargo
$54.74

0.26 (0.48%)

04/16/18
BARD
04/16/18
NO CHANGE
Target $62
BARD
Outperform
Lower expectations limit Wells Fargo downside, says Baird
Baird analyst David George said Wells Fargo reported messy Q1 results, but lowered expectations should limit the downside in the shares. The analyst said core fees were weak, but expenses were in line as was loan growth. George maintained his Outperform rating and $62 price target on Wells Fargo shares.
04/30/18
04/30/18
UPGRADE

Outperform
Wells Fargo double upgraded to Outperform at Macquarie
Macquarie analyst David Konrad upgraded Wells Fargo to Outperform from Underperform with a $61 price target citing attractive valuation, low expectations, and near-term catalysts. Konrad said valuation and consensus estimates have finally come down and said shares are trading at 11.3x his 2019 "stressed earnings" estimate, compared to super regionals trading at 12.3x. The analyst expects low expense guidance at the upcoming investor day and passing CCAR in June to serve as positive catalysts for shares.
04/16/18
NOMU
04/16/18
NO CHANGE
Target $68
NOMU
Buy
Wells Fargo earnings underwhelming, but not a value trap, says Nomura
Nomura Instinet analyst Bill Carcache lowered his price target for Wells Fargo to $68 from $72 saying Friday's earnings results were "underwhelming" as the company reported softer revenue growth. The analyst, however, continues to believe that shares of Wells Fargo are "not a value trap." Shareholders "able to weather the current storm" will be rewarded with 10% earnings growth, mid- to high-teens return on tangible equity, and a multiple rerating when the market regains confidence, Carcache tells investors in a research note. He keeps a Buy rating on the shares.
04/17/18
BMOC
04/17/18
NO CHANGE
Target $34
BMOC
Market Perform
Bank of America is the best of the 'big four' U.S. banks, says BMO Capital
BMO Capital analyst James Fotheringham kept his Market Perform rating and $34 price target on Bank of America (BAC) after its in-line Q1 earnings but raised his FY18 EPS view to $2.62 from $2.59 and FY19 view to $3.18 from $3.12. Fotheringham says than in contrast, he lowered earnings forecasts for JPMorgan (JPM), Wells Fargo (WFC), and Citigroup (C) because of higher costs and lower revenues, but Bank of America's better than expected net interest income rise justifies his view of the bank as the "best of the bunch". The analyst also notes the bank's more favorable valuation trading at a below-average two-year-forward P/E multiple despite his forecast of double the core earnings growth rate of Bank of America's peers.
BYD Boyd Gaming
$36.15

0.095 (0.26%)

03/13/18
TLSY
03/13/18
INITIATION
TLSY
Market Perform
Boyd Gaming initiated with a Market Perform at Telsey Advisory
05/01/18
LEHM
05/01/18
UPGRADE
Target $40
LEHM
Overweight
Boyd Gaming upgraded to Overweight from Equal Weight at Barclays
Barclays analyst Felicia Hendrix upgraded Boyd Gaming to Overweight and raised her price target for the shares to $40 from $33. The consumer remains strong, particularly in Las Vegas, while Boyd is embarking on profitability enhancing initiatives across is portfolio, Hendrix tells investors in a research note.
05/14/18
JEFF
05/14/18
NO CHANGE
JEFF
Jefferies says Penn National, Caesars among winners from sports gaming ruling
After the Supreme Court ruled that the PASPA provision prohibiting state authorization of organized sports gambling violates the tenth amendment, Jefferies analyst David Katz reiterated his view on which companies are positioned to be key beneficiaries of the decision. He continues to identify Penn National (PENN) and Caesars (CSR) as among the top winners in terms of casino operators, followed by Eldorado Resorts (ERI), Churchill Downs (CHDN), Boyd Gaming (BYD), Monarch Casino (MCRI), and MGM Resorts (MGM). He also sees "location-agnostic" suppliers Scientific Games (SGMS) and International Game (IGT) as winners, Katz tells investors.
05/15/18
BOFA
05/15/18
NO CHANGE
BOFA
Supreme Court ruling on sports betting positive for regionals, game tech, says BofA/Merrill
BofA/Merrill analyst Shaun Kelley notes that the Supreme Court ruled 6-3 to repeal the Professional and Amateur Sports Protection Act, which had effectively banned full sports betting in every state except Nevada. While the analyst expects operator margins to be low, he sees upside for all of regional gaming, while gaming tech could be a key beneficiary. Reflecting sports betting in higher multiples, Kelley raised his price targets for Boyd Gaming (BYD) to $45 from $42, Penn National (PENN) to $36 from $32, Scientific Games (SGMS) to $70 from $60, and International Game (IGT) to $36 from $34.
SGMS Scientific Games
$58.80

-0.5 (-0.84%)

02/20/18
JEFF
02/20/18
INITIATION
Target $57
JEFF
Buy
Scientific Games initiated with a Buy at Jefferies
Jefferies analyst David Katz started Scientific Games with a Buy rating and $57 price target. The analyst calls the company his Focus Pick in the equipment and technology supplier segment of the gaming industry. Katz views the current valuation as "highly attractive" following the NYX acquisition and his sum of the parts analysis yields share prices of $56 and $76 per share on 2018 and 2019 estimates.
10/05/17
CHLM
10/05/17
NO CHANGE
Target $56
CHLM
Buy
Scientific Games price target raised to $56 from $45 at Craig-Hallum
Craig-Hallum analyst Mike Malouf raised his price target for Scientific Games to $56 from $45 saying that its new CEO Kevin Sheehan has started to guide the company into the execution stage of its transformation. The new CEO has completed the cost rationalization initiative, which should further drive free cash flow this year, and the company is taking advantage of the market to refinance some of its debt, lowering the effective interest rate and driving continued free cash flow growth, he adds. Malouf reiterates a Buy rating on the shares.
RRR Red Rock Resorts
$33.89

0.2 (0.59%)

03/13/18
TLSY
03/13/18
INITIATION
TLSY
Market Perform
Red Rock Resorts initiated with a Market Perform at Telsey Advisory
05/08/18
NOMU
05/08/18
INITIATION
Target $39
NOMU
Buy
Red Rock Resorts initiated with a Buy at Nomura Instinet
Nomura Instinet analyst Henry Curtis started Red Rock Resorts with a Buy rating and $39 price target.
04/03/18
MACQ
04/03/18
DOWNGRADE
MACQ
Neutral
Red Rock Resorts downgraded to Neutral from Outperform at Macquarie
04/03/18
04/03/18
DOWNGRADE

Neutral
Red Rock Resorts downgraded to Neutral on valuation at Macquarie
As previously reported, Macquarie downgraded Red Rock Resorts to Neutral from Buy. Analyst Chad Beynon said shares reflect the future equity value from Palms and Palace Station and lowered his price target to $32 from $34 on shares.
MCRI Monarch Casino
$43.89

0.47 (1.08%)

01/18/18
JEFF
01/18/18
INITIATION
Target $39
JEFF
Underperform
Monarch Casino initiated with an Underperform at Jefferies
Jefferies analyst David Katz initiated Monarch Casino with an Underperform and $39 price target.
10/25/17
UGAM
10/25/17
UPGRADE
UGAM
Buy
Monarch Casino upgraded to Buy from Hold at Union Gaming
TSG The Stars Group
$35.75

-0.75 (-2.05%)

04/23/18
DESJ
04/23/18
UPGRADE
DESJ
Buy
The Stars Group upgraded to Buy from Hold at Desjardins
Desjardins analyst Maher Yaghi upgraded The Stars Group to Buy from Hold.
05/11/18
DESJ
05/11/18
DOWNGRADE
DESJ
Hold
The Stars Group downgraded to Hold from Buy at Desjardins
TAST Carrols Restaurant
$11.90

-0.05 (-0.42%)

02/28/18
SPHN
02/28/18
NO CHANGE
SPHN
Carrols Restaurant's Q4 'impressive,' says Stephens
Stephens analyst Will Slabaugh was positive on Carrols Restaurant's beat and raise Q4 results, and likes the story for "its strong acquisition pipeline, associated cost opportunities, and general out-performance" within quick service restaurants. Slabaugh kept an Overweight rating and $18 price target on Carrols Restaurant shares, which be believes are materially undervalued at current levels.
09/26/17
RAJA
09/26/17
DOWNGRADE
RAJA
Outperform
Carrols Restaurant downgraded to Outperform from Strong Buy at Raymond James
09/26/17
09/26/17
DOWNGRADE
Target $15.5

Outperform
Carrols Restaurant downgraded to Outperform from Strong Buy at Raymond James
As previously reported, Raymond James downgraded Carrols Restaurant to Outperform from Strong Buy and maintained a $15.50 price target. Analyst Brian Vaccaro expects a higher level of discounting/promotions will pressure second half Burger King store margins, combined with high labor costs. As a result, the analyst lowered his 2017 EBITDA estimate to $87M, below guidance of $90M-$95M.
06/12/17
RAJA
06/12/17
NO CHANGE
Target $17
RAJA
Strong Buy
Carrols Restaurant recent weakness a buying opportunity, says Raymond James
Raymond James analyst Brian Vaccaro said near-term beef concerns has created an attractive entry point for Carrols Restaurant shares. The analyst said near-term comp acceleration will more than offset beef costs that he expects to moderate. With shares down approximately 10% in the past month, he would buy shares as he expects margin visibiliy to improve later in the year. Vaccaro rates Carrols a Strong Buy with a $17 price target.
EVRI Everi Holdings
$7.48

0.03 (0.40%)

03/13/18
TLSY
03/13/18
INITIATION
TLSY
Outperform
Everi Holdings initiated with an Outperform at Telsey Advisory
02/20/18
JEFF
02/20/18
INITIATION
Target $11
JEFF
Buy
Everi Holdings initiated with a Buy at Jefferies
Jefferies analyst David Katz started Everi Holdings with a Buy rating and $11 price target. The analyst views the company's "stable" payments business with the double-digit growing gaming machine business as "financially compelling given the positive dynamics of the casino industry."
06/12/17
STFL
06/12/17
NO CHANGE
STFL
Everi Holdings momentum continuing, says Stifel
After meeting with Everi's management, Stifel analyst John Davis says that "the company has continued to build on recent momentum, especially in the Games business." He thinks that the stock has one of the best risk/reward ratios in his coverage and raised the price target on the shares to $9 from $7.50 while keeping a Buy rating on the stock.
08/14/17
STFL
08/14/17
NO CHANGE
STFL
Everi Holdings added to Select List at Stifel
Stifel analyst John Davis added Everi Holdings to the firm's Select List, saying that the stock's decline following the company's Q2 results was "unwarranted." He recommends that investors buy the stock on weakness.
GDEN Golden Entertainment
$29.76

0.92 (3.19%)

03/13/18
TLSY
03/13/18
INITIATION
TLSY
Outperform
Golden Entertainment initiated with an Outperform at Telsey Advisory
10/25/17
MACQ
10/25/17
INITIATION
Target $34
MACQ
Outperform
Golden Entertainment initiated with an Outperform at Macquarie
Macquarie analyst Chad Beynon initiated Goldan Entertainment with an Outperform and $35 price target saying it runs a highly scalable business with heavy exposure to Southern Nevada, which is arguably the healthiest US economy. Further, the company has industry-leading exposure to millennial's spending given its Tavern concept which includes Food/Beverage and approximately 15 slot machines primarily to Vegas residents
01/18/18
JEFF
01/18/18
INITIATION
Target $38
JEFF
Buy
Golden Entertainment initiated with a Buy at Jefferies
Jefferies analyst David Katz initiated Golden Entertainment with a Buy and $38 price target.
04/13/18
JEFF
04/13/18
NO CHANGE
JEFF
Jefferies sees opportunity in smid-cap casino stocks after selloff
The recent selloff in smid-cap casino stocks has been driven by the impact of severe weather in the regional markets as well as a challenging quarter in Las Vegas, Jefferies analyst David Katz tells investors in a research note. Following the release of positive March gross gaming revenue from several important regional markets, the context for the quarter is more positive, Katz adds. He believes the share selloff is overdone and presents opportunities in Caesars (CZR) and Penn National Gaming (PENN), among others.
MGP MGM Growth
$28.41

-0.26 (-0.91%)

04/08/18
EVER
04/08/18
UPGRADE
EVER
Outperform
MGM Growth upgraded to Outperform from In Line at Evercore ISI
06/02/17
LTCO
06/02/17
INITIATION
Target $32
LTCO
Buy
MGM Growth initiated with a Buy at Ladenburg
Ladenburg Thalmann analyst Daniel Donlan started MGM Growth Properties with a Buy rating and $32 price target. The company's underlying cash flow strength of its gaming/destination resort assets "look highly attractive" relative to traditional net leas, the analyst contends.
02/15/18
MSCO
02/15/18
INITIATION
Target $29
MSCO
Equal Weight
MGM Growth resumed with an Equal Weight at Morgan Stanley
Morgan Stanley analyst Thomas Allen resumed coverage of MGM Growth Properties with an Equal Weight rating and $29 price target, saying that while he sees Gaming REITs as well positioned to grow, rising interest rates and increased competition are risks.
09/08/17
JPMS
09/08/17
NO CHANGE
Target $39
JPMS
Overweight
National Harbor deal positive for MGM, MGM Growth, says JPMorgan
JPMorgan analyst Joseph Greff has a favorable view of both MGM Resorts (MGM) and MGM Growth Properties (MGP) as it relates to the purchase of MGM National Harbor's real estate for $1.1875B. For MGM Growth, the deal is accretive and represents a good valuation multiple, Greff tells investors in a research note. He upped his price target for the shares to $33 from $31. For MGM, the transaction improves the balance sheet and helps accelerate the return of capital via a $1B share repurchase authorization, the analyst writes. He upped his price target for those shares to $39 from $37. He keeps Overweight ratings on both stocks.
PENN Penn National
$33.98

0.23 (0.68%)

04/26/18
RHCO
04/26/18
UPGRADE
RHCO
Buy
Penn National upgraded to Buy from Hold at SunTrust
04/27/18
RHCO
04/27/18
UPGRADE
Target $35
RHCO
Buy
Penn National upgraded to Buy at SunTrust on valuation
As reported earlier, SunTrust analyst C. Patrick Scholes upgraded Penn National to Buy from Hold and kept his $35 price target. Scholes says that the discount with which the company trades relative to its peers is "extreme" even though it has underperformed the competition, adding that companies with "objectively lower end portfolios" trade with a higher multiple. The analyst also notes that Penn National has some upside catalysts, including cost synergies from its acquisitions.
MGM MGM Resorts
$31.73

-0.58 (-1.80%)

04/26/18
JEFF
04/26/18
NO CHANGE
JEFF
Buy
MGM Resorts pullback a buying opportunity, says Jefferies
Jefferies analyst David Katz views the post-earnings pullback in shares of MGM Resorts as a buying opportunity. The analyst views the report as a neutral for the stock given the pressure in Las Vegas.
04/23/18
SUSQ
04/23/18
UPGRADE
SUSQ
Positive
MGM Resorts upgraded to Positive from Neutral at Susquehanna
05/07/18
JEFF
05/07/18
NO CHANGE
Target $43
JEFF
Buy
MGM analyst meeting should move shares higher, says Jefferies
Jefferies analyst David Katz expects shares of MGM Resorts to react positively to Thursday's analyst meeting. The analyst thinks the presentation will focus on growth and capital allocation. He reiterates a Buy rating on MGM with a $43 price target.
CZR Caesars
$12.70

0.2 (1.60%)

03/07/18
NOMU
03/07/18
UPGRADE
NOMU
Buy
Caesars upgraded to Buy from Neutral at Nomura Instinet
04/05/18
NOMU
04/05/18
NO CHANGE
Target $15
NOMU
Buy
Nomura sees 'several' positive catalysts to reverse Caesars sentiment
Nomura Instinet analyst Harry Curtis sees "several" positive catalysts that could reverse the negative sentiment on shares of Caesars. These include Q2 RevPAR strength in Las Vegas, which is being underappreciated by investors, Curtis tells investors in a research note. He notes the stock has 36% upside potential to his $15 price target along with a 13% free cash flow yield on 2019 estimates. Curtis keeps a Buy rating on Caesars.
ERI Eldorado Resorts
$43.10

-0.1 (-0.23%)

05/08/18
NOMU
05/08/18
INITIATION
Target $47
NOMU
Neutral
Eldorado Resorts initiated with a Neutral at Nomura Instinet
Nomura Instinet analyst Henry Curtis started Eldorado Resorts with a Neutral rating and $47 price target.
05/04/18
RHCO
05/04/18
NO CHANGE
Target $49
RHCO
Buy
Eldorado Resorts price target raised to $49 from $37 at SunTrust
SunTrust analyst C. Patrick Scholes raised his price target on Eldorado Resorts to $49 and kept his Buy rating after its Q1 results. Schoes says that despite the earnings miss on weather-related factors, the company's longer term opportunities of a Florida JV and pending purchases look compelling.
05/04/18
JPMS
05/04/18
NO CHANGE
Target $55
JPMS
Overweight
Eldorado Resorts price target raised to $55 from $47 at JPMorgan
JPMorgan analyst Daniel Politzer raised his price target for Eldorado Resorts to $55 saying the company's multi-year EBITDA growth story is emerging. Eldorado's Q1 EBITDA miss reflects adverse weather and higher corporate expense, but investors should be focused on the "bigger picture coming into focus" following the recently announced deals, Politzer tells investors in a research note. He believes the company is positioned for "multiple years of significant EBITDA growth." The analyst keeps an Overweight rating on Eldorado Resorts.

TODAY'S FREE FLY STORIES

NVS

Novartis

$87.74

0.52 (0.60%)

, DBVT

DBV Technologies

$16.70

0.31 (1.89%)

04:55
11/18/18
11/18
04:55
11/18/18
04:55
Conference/Events
American College of Allergy, Asthma & Immunology to hold a meeting »

2018 ACAAI Meeting will…

NVS

Novartis

$87.74

0.52 (0.60%)

DBVT

DBV Technologies

$16.70

0.31 (1.89%)

REGN

Regeneron

$345.10

3.56 (1.04%)

SHPG

Shire

$175.59

-3.39 (-1.89%)

TEVA

Teva

$22.25

-0.37 (-1.64%)

SNY

Sanofi

$45.11

0.56 (1.26%)

GSK

GlaxoSmithKline

$40.35

-0.06 (-0.15%)

AZN

AstraZeneca

$40.67

-0.685 (-1.66%)

CHD

Church & Dwight

$65.42

-0.39 (-0.59%)

BSX

Boston Scientific

$37.22

0.75 (2.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 30

    Nov

  • 02

    Dec

  • 03

    Dec

  • 21

    Dec

  • 28

    Jan

  • 11

    Mar

  • 22

    Mar

  • 28

    Apr

  • 13

    May

PDVW

pdvWireless

$39.84

0.06 (0.15%)

16:30
11/17/18
11/17
16:30
11/17/18
16:30
Conference/Events
pdvWireless management to meet with Morgan Stanley »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBS

CBS

$57.49

0.23 (0.40%)

16:28
11/17/18
11/17
16:28
11/17/18
16:28
Conference/Events
CBS management to meet with Morgan Stanley »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

THS

TreeHouse

$51.92

0.72 (1.41%)

, CAG

Conagra Brands

$33.09

0.66 (2.04%)

12:54
11/17/18
11/17
12:54
11/17/18
12:54
Periodicals
Treehouse Foods stock may have room to gain, Barron's says »

Treehouse Foods (THS)…

THS

TreeHouse

$51.92

0.72 (1.41%)

CAG

Conagra Brands

$33.09

0.66 (2.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMGN

Amgen

$194.23

1.83 (0.95%)

12:51
11/17/18
11/17
12:51
11/17/18
12:51
Periodicals
Amgen may be 'a remedy' for tougher times, Barron's says »

Amgen may be a stock that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 01

    Dec

  • 02

    Dec

  • 03

    Dec

  • 03

    Dec

AAPL

Apple

$193.42

2 (1.04%)

, LITE

Lumentum

$41.50

0.46 (1.12%)

12:47
11/17/18
11/17
12:47
11/17/18
12:47
Periodicals
Apple stock could continue to slide, Barron's says »

Apple's (AAPL) stock…

AAPL

Apple

$193.42

2 (1.04%)

LITE

Lumentum

$41.50

0.46 (1.12%)

QRVO

Qorvo

$66.32

1.18 (1.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APC

Anadarko

$56.39

0.9 (1.62%)

, RDS.B

Royal Dutch Shell

$63.97

0.19 (0.30%)

12:41
11/17/18
11/17
12:41
11/17/18
12:41
Periodicals
Investors may find bargains among oil, natural gas stocks, Barron's says »

Investors have been…

APC

Anadarko

$56.39

0.9 (1.62%)

RDS.B

Royal Dutch Shell

$63.97

0.19 (0.30%)

RDS.A

Royal Dutch Shell

$62.02

0.34 (0.55%)

XOM

Exxon Mobil

$78.99

0.81 (1.04%)

CVX

Chevron

$119.14

2.18 (1.86%)

BP

BP

$40.85

-0.3 (-0.73%)

EOG

EOG Resources

$105.21

3.57 (3.51%)

OXY

Occidental Petroleum

$73.32

0.71 (0.98%)

COG

Cabot Oil & Gas

$25.73

0.09 (0.35%)

EQT

EQT Corporation

$16.62

-0.55 (-3.20%)

HAL

Halliburton

$32.46

0.02 (0.06%)

SLB

Schlumberger

$48.24

0.17 (0.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 18

    Jan

  • 22

    Jan

LB

L Brands

$35.28

-0.41 (-1.15%)

, JCP

J.C. Penney

$1.29

-0.08 (-5.84%)

12:34
11/17/18
11/17
12:34
11/17/18
12:34
Periodicals
Kohl's, Target set to thrive this holiday season, Barron's says »

Store chains have been…

LB

L Brands

$35.28

-0.41 (-1.15%)

JCP

J.C. Penney

$1.29

-0.08 (-5.84%)

TJX

TJX

$51.47

-0.98 (-1.87%)

BBY

Best Buy

$66.41

-1.34 (-1.98%)

TIF

Tiffany

$106.48

0.52 (0.49%)

HD

Home Depot

$177.11

-0.25 (-0.14%)

TGT

Target

$79.67

-1.09 (-1.35%)

KSS

Kohl's

$72.48

-0.7 (-0.96%)

AMZN

Amazon.com

$1,593.59

-26.41 (-1.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 28

    Nov

  • 04

    Dec

  • 05

    Dec

  • 03

    Mar

T

AT&T

$30.30

0.18 (0.60%)

, FOX

21st Century Fox

$47.73

-0.1 (-0.21%)

09:18
11/17/18
11/17
09:18
11/17/18
09:18
OnTheFly
Week in review: How Trump's policies moved stocks »

Catch up on the top…

T

AT&T

$30.30

0.18 (0.60%)

FOX

21st Century Fox

$47.73

-0.1 (-0.21%)

FOXA

21st Century Fox

$48.18

-0.11 (-0.23%)

AMZN

Amazon.com

$1,593.59

-26.41 (-1.63%)

CMCSA

Comcast

$38.60

0.11 (0.29%)

CMCSK

Comcast

$0.00

(0.00%)

DDAIF

Daimler AG

$0.00

(0.00%)

FCAU

Fiat Chrysler

$16.46

-0.12 (-0.72%)

F

Ford

$9.05

-0.26 (-2.79%)

GM

General Motors

$35.76

0.21 (0.59%)

HMC

Honda

$28.21

0.01 (0.04%)

NSANY

Nissan

$0.00

(0.00%)

TM

Toyota

$116.87

-0.02 (-0.02%)

VLKAY

Volkswagen

$0.00

(0.00%)

NYT

New York Times

$26.30

-0.2 (-0.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 03

    Dec

  • 04

    Dec

  • 13

    Dec

  • 23

    Jan

  • 25

    Apr

  • 24

    Jul

  • 23

    Oct

NVS

Novartis

$87.74

0.52 (0.60%)

, DBVT

DBV Technologies

$16.70

0.31 (1.89%)

04:55
11/17/18
11/17
04:55
11/17/18
04:55
Conference/Events
American College of Allergy, Asthma & Immunology to hold a meeting »

2018 ACAAI Meeting will…

NVS

Novartis

$87.74

0.52 (0.60%)

DBVT

DBV Technologies

$16.70

0.31 (1.89%)

REGN

Regeneron

$345.10

3.56 (1.04%)

SHPG

Shire

$175.59

-3.39 (-1.89%)

TEVA

Teva

$22.25

-0.37 (-1.64%)

SNY

Sanofi

$45.11

0.56 (1.26%)

GSK

GlaxoSmithKline

$40.35

-0.06 (-0.15%)

AZN

AstraZeneca

$40.67

-0.685 (-1.66%)

CHD

Church & Dwight

$65.42

-0.39 (-0.59%)

BSX

Boston Scientific

$37.22

0.75 (2.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 30

    Nov

  • 02

    Dec

  • 03

    Dec

  • 21

    Dec

  • 28

    Jan

  • 11

    Mar

  • 22

    Mar

  • 28

    Apr

  • 13

    May

MSI

Motorola Solutions

$129.97

0.72 (0.56%)

18:48
11/16/18
11/16
18:48
11/16/18
18:48
Hot Stocks
Motorola Solutions: ITC confirms Hytera products infringe Motorola patents »

Motorola Solutions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 18

    Dec

  • 19

    Dec

PCG

PG&E

$24.39

6.62 (37.25%)

18:23
11/16/18
11/16
18:23
11/16/18
18:23
Periodicals
CPUC isn't ruling out board shuffle, breakup for PG&E, Bloomberg says »

The California Public…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABX

Barrick Gold

$13.04

0.05 (0.38%)

18:00
11/16/18
11/16
18:00
11/16/18
18:00
Periodicals
Barrick Gold looking to add more copper, bullion assets, Reuters reports »

Barrick Gold is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WTR

Aqua America

$33.05

0.165 (0.50%)

17:57
11/16/18
11/16
17:57
11/16/18
17:57
Hot Stocks
Aqua America CEO acquires over 25,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLRE

Real Estate SPDR

$33.45

0.445 (1.35%)

, XLB

S&P Select Materials SPDR

$55.23

0.53 (0.97%)

17:39
11/16/18
11/16
17:39
11/16/18
17:39
General news
Week ending ETF scorecard: Real Estate leads, Consumer Discretionary slumps »

S&P500 SECTORS: Real…

XLRE

Real Estate SPDR

$33.45

0.445 (1.35%)

XLB

S&P Select Materials SPDR

$55.23

0.53 (0.97%)

XLU

Utilities SPDR

$54.86

0.77 (1.42%)

XLI

Industrial Select Sector SPDR

$72.00

(0.00%)

XLV

Health Care Select Sector SPDR

$92.05

0.91 (1.00%)

XLF

Financial Select Sector

$26.78

0.03 (0.11%)

XLP

Consumer Staples Sector SPDR

$56.04

0.15 (0.27%)

XLE

Energy Select Sector SPDR

$67.23

0.76 (1.14%)

XLC

Communication Services Select Sector SPDR Fund

$44.88

-0.2 (-0.44%)

XLK

Technology Select Sector SPDR

$68.22

-0.1 (-0.15%)

XLY

Consumer Discretionary Sector SPDR

$106.37

-0.43 (-0.40%)

GLD

SPDR Gold Shares

$115.56

0.82 (0.71%)

SLV

iShares Silver Trust

$13.55

0.115 (0.86%)

USO

United States Oil Fund

$12.07

0.08 (0.67%)

UNG

United States Natural Gas Fund

$35.43

3.63 (11.42%)

HYG

iShares iBoxx $ High Yield Corporate Bond

$83.24

-0.27 (-0.32%)

LQD

iShares iBoxx $ Investment Grade Corporate Bond

$111.73

0.23 (0.21%)

TLT

iShares 20+ Year Treasury Bond Fund

$114.65

0.61 (0.53%)

IEF

iShares 7-10 Year Treasury Bond ETF

$101.13

0.3 (0.30%)

SHY

iShares 1-3 Year Treasury Bond

$83.13

0.08 (0.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AQST

Aquestive Therapeutics

$17.02

0.23 (1.37%)

17:36
11/16/18
11/16
17:36
11/16/18
17:36
Hot Stocks
Aquestive receives CRL from FDA for tadalafil oral film »

Aquestive Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

DAKT

Daktronics

$7.67

0.07 (0.92%)

17:35
11/16/18
11/16
17:35
11/16/18
17:35
Hot Stocks
Daktronics adopts new shareholder rights agreement »

Daktronics announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

TI

Telecom Italia

$6.02

0.12 (2.03%)

17:33
11/16/18
11/16
17:33
11/16/18
17:33
Periodicals
Gubitosi viewed as frontrunner for Telecom Italia CEO job, Reuters says »

Veteran Italian manager…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MAXR

Maxar Technologies

$18.77

-0.59 (-3.05%)

17:30
11/16/18
11/16
17:30
11/16/18
17:30
Hot Stocks
Maxar Technologies shareholders approve U.S. domestication »

Maxar Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PLUG

Plug Power

$1.83

(0.00%)

17:28
11/16/18
11/16
17:28
11/16/18
17:28
Syndicate
Breaking Syndicate news story on Plug Power »

Plug Power files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GSB

GlobalSCAPE

$4.55

-0.02 (-0.44%)

17:22
11/16/18
11/16
17:22
11/16/18
17:22
Syndicate
Breaking Syndicate news story on GlobalSCAPE »

GlobalSCAPE files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EQIX

Equinix

$388.18

2.67 (0.69%)

17:19
11/16/18
11/16
17:19
11/16/18
17:19
Hot Stocks
Equinix's Lee sells 2,792 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 10

    Dec

LMT

Lockheed Martin

$301.06

-4.42 (-1.45%)

17:17
11/16/18
11/16
17:17
11/16/18
17:17
Hot Stocks
Lockheed Martin awarded $282.09M Naval Sea Systems Command contract »

Lockheed Martin has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TLGT

Teligent

$2.56

0.045 (1.79%)

17:16
11/16/18
11/16
17:16
11/16/18
17:16
Hot Stocks
Teligent receives notification of deficiency from Nasdaq »

Teligent said that on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STAF

Staffing 360 Solutions

$1.82

0.07 (4.00%)

17:16
11/16/18
11/16
17:16
11/16/18
17:16
Syndicate
Breaking Syndicate news story on Staffing 360 Solutions »

Staffing 360 Solutions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.